Neurotoxin Market Analysis Report 2023 to 2028
Neurotoxin Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 6.62 Billion |
| Market Size by 2028 | US$ 13.2 Billion |
| Global CAGR (2022 - 2028) | 12.3% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Neurotoxins – Market Segmentation
The global neurotoxin market is segmented on the basis of products type, application, and end user. Based on products type, the market is divided into Botox, Dysport, Xeomin, and others. The Botox segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period. Based on application, the global neurotoxin market is segmented into therapeutic and aesthetic. Based on end user, the market is segmented into hospitals, dermatology clinics, medical spas, and others.
Based on geography, the neurotoxin market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, Poland, Russia, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East (the UAE, Saudi Arabia, South Africa, Israel, Lebanon, and the Rest of Middle East), and South & Central America (Brazil, Argentina, Venezuela, and the Rest of South & Central America).
Company Profiles – Neurotoxin Market
- Merz Pharma GmbH & Co KGaA
- AbbVie Inc
- Revance Therapeutics Inc
- Ipsen SA
- Medytox Inc
- Evolus Inc
- Hugel Inc
- Lanzhou Institute of Biological Products Co Ltd
- Gufic
- Metabiologics, Inc.
Get Free Sample For